During the hybrid Eurostars show in Amsterdam, Protinhi Therapeutics has managed for the second time to get their highest ranking Eurostars program approved. The company is placed in the biotech sector and focuses on developing antivirals against viral threats, such as the famous coronavirus. Their new program will also be focused on the virus, finding innovating approaches via diagnostics and therapeutics. They do this working with their partners Sciomics and Artemis Bio-Support.

Click here for more information about the announcement. Interested in learning more about the working activities of Protinhi Therapeutics? Visit their website via this link.